FDA IOM: Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease Thomas Sullivan May 26, 2010 0 In 2008, the Food and Drug Administration (FDA) asked the Institute of Medicine (IOM) to conduct a study on the evaluation…
Conflict of Interest FDA Transparency Initiative: Draft Disclosure Policies Thomas Sullivan May 25, 2010 1 In addition to the recently published Nation Institutes of Health (NIH) transparency Guidelines, the Food and Drug Administration…
Medical Legal Astra Zeneca Seroquel Settlement and Corporate Integrity Agreement Thomas Sullivan Apr 29, 2010 2 Under the Food, Drug and Cosmetic Act, a company must specify the intended uses of a product in its new drug application to the…
FDA Building a Comparative FDA May Not Lead to Effectiveness Thomas Sullivan Mar 25, 2010 0 A recent article in the Journal of the American Medical Association (JAMA) discusses how to “Build Comparative Efficacy and…
FDA FDA Educates Industry on Development of Orphan Drugs Thomas Sullivan Mar 11, 2010 0 In the complex and expensive world of research and development for drugs, there are therapies for conditions known as “orphan…
Congress GAO Recommends the FDA to Strengthen Investigation Oversight Thomas Sullivan Mar 9, 2010 0 Within the Food and Drug Administration (FDA) is the Office of Criminal Investigations (OCI), which investigates individuals and…
Conflict of Interest Fox Stossel Show: Hands Off My Healthcare Thomas Sullivan Feb 25, 2010 1 Tonight at 8:00pm and 11:00pm EST on the Fox Businesses Channel, John Stossel, host of "Stossel" on the Fox Business…
Congress Letters from Grassley: FDA to Clarify Policies on Medical Devices Thomas Sullivan Feb 19, 2010 0 This week, Senator Charles Grassley (R-IA), ranking member of the Senate Finance Committee, issued a press release asking the Food…
FDA Five Part Podcast Series on FDA Features John Kamp of Coalition for… Thomas Sullivan Feb 18, 2010 0 A new five-part Podcast series was recently announced by Med Ad News editors Steven Niles and Joshua Slatko. The series will…
Conflict of Interest FDA Official Cleared of Conflict Allegations in Heparin Contamination Case Thomas Sullivan Feb 8, 2010 0 Last week Janet Woodcock, director of the Center for Drug Evaluation and Research at the FDA was cleared of a conflict of interest…